Biotech Akeso’s 2024 Results: Strengthening Global Competitiveness and Transforming the Treatment Landscape with Bispecific Antibodies March 31, 2025
Biotech Oral semaglutide 14 mg demonstrated superior reduction in risk of cardiovascular events in late-breaking SOUL trial presented at the American College of Cardiology March 30, 2025
Biotech FDA Approves Novel Treatment for Hemophilia A or B, with or without Factor Inhibitors March 29, 2025
Biotech ARTHEx Biotech to Participate in the 24th Annual Needham Virtual Healthcare Conference March 27, 2025
Biotech Clover Announces U.S. IND Clearance and Initiation of Revaccination Clinical Study for RSV Vaccine Candidate SCB-1019 March 25, 2025
Biotech Multiple Myeloma Market to Witness Substantial Growth — Key Trends and Forecasts of Different Reports for the Next Decade | DelveInsight March 19, 2025
Biotech Latigo Biotherapeutics Closes $150 Million in Series B Financing to Advance Non-Opioid Pain Therapeutics March 17, 2025